A Double-Blind, Randomized, Placebo-Controlled Trial of Divalproex Extended-Release in the Treatment of Bipolar Disorder in Children and Adolescents

Extended Release ◽

Controlled Trial ◽

Faculty Opinions recommendation of A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1163501.625237 ◽

2009 ◽

Author(s):

Robert Findling

Keyword(s):

Bipolar Disorder ◽

Extended Release ◽

Controlled Trial ◽

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Extended-Release Carbamazepine Capsules as Monotherapy for Bipolar Disorder Patients With Manic or Mixed Episodes

The Journal of Clinical Psychiatry ◽

10.4088/jcp.v65n0405 ◽

2004 ◽

Vol 65 (4) ◽

pp. 478-484 ◽

Cited By ~ 131

Author(s):

Richard H. Weisler ◽

Amir H. Kalali ◽

Terence A. Ketter ◽

Keyword(s):

Bipolar Disorder ◽

Extended Release ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Faculty Opinions recommendation of A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.30746.487248 ◽

2006 ◽

Author(s):

Alan Apter

Keyword(s):

Bipolar Disorder ◽

Controlled Trial ◽

A Double-Blind, Randomized, Placebo-Controlled Trial of Oxcarbazepine in the Treatment of Bipolar Disorder in Children and Adolescents

American Journal of Psychiatry ◽

10.1176/ajp.2006.163.7.1179 ◽

2006 ◽

Vol 163 (7) ◽

pp. 1179-1186 ◽

Cited By ~ 78

Author(s):

Karen Dineen Wagner ◽

Robert A. Kowatch ◽

Graham J. Emslie ◽

Robert L. Findling ◽

Timothy E. Wilens ◽

...

Keyword(s):

Bipolar Disorder ◽

Controlled Trial ◽

A Double-Blind, Randomized, Placebo-Controlled Trial of Oxcarbazepine in the Treatment of Bipolar Disorder in Children and Adolescents

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)70623-6 ◽

2008 ◽

Vol 2008 ◽

pp. 8-9

Author(s):

R.M. Sarles

Keyword(s):

Bipolar Disorder ◽

Controlled Trial ◽

How to (tr)eat?: A double-blind randomized controlled trial investigating broad-spectrum micronutrients in highly impulsive children and adolescents

10.1055/s-0039-1679186 ◽

2019 ◽

Author(s):

K Mechler ◽

T Banaschewski ◽

R Berg ◽

A Dietrich ◽

P Hoekstra ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Broad Spectrum ◽

Controlled Trial ◽

Double Blind ◽

Randomized Controlled

Faculty Opinions recommendation of Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13436981.14828060 ◽

2012 ◽

Author(s):

Phillip Lieberman ◽

Jay Lieberman

Keyword(s):

Eosinophilic Esophagitis ◽

Controlled Trial ◽

708 RESULTS OF A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐AND ACTIVE‐CONTROLLED TRIAL OF TAPENTADOL EXTENDED RELEASE FOR CHRONIC LOW BACK PAIN

European Journal of Pain ◽

10.1016/s1090-3801(09)60711-4 ◽

2009 ◽

Vol 13 (S1) ◽

Cited By ~ 1

Author(s):

D.Y. Shapiro ◽

R. Buynak ◽

A. Okamoto ◽

I. Hove ◽

A. Steup ◽

...

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Extended Release ◽

Controlled Trial ◽

Low Back ◽

Double Blind ◽

Double Blind Placebo

Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2015.10.014 ◽

2015 ◽

Vol 37 (12) ◽

pp. 2780-2787 ◽

Cited By ~ 16

Author(s):

Angela Applebee ◽

Andrew D. Goodman ◽

Angeli S. Mayadev ◽

Francois Bethoux ◽

Myla D. Goldman ◽

...

Keyword(s):

Multiple Sclerosis ◽

Extended Release ◽

Controlled Trial ◽

Walk Distance ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Post Hoc ◽

Minute Walk Distance ◽

Minute Walk

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

The Lancet Psychiatry ◽

10.1016/s2215-0366(17)30166-9 ◽

2017 ◽

Vol 4 (8) ◽

pp. 605-618 ◽

Cited By ~ 20

Author(s):

Anne Katrine Pagsberg ◽

Pia Jeppesen ◽

Dea Gowers Klauber ◽

Karsten Gjessing Jensen ◽

Ditte Rudå ◽

...

Keyword(s):

Extended Release ◽

First Episode Psychosis ◽

First Episode ◽

Double Blind ◽

Episode Psychosis